Hemogenyx Pharmaceuticals buy melinda
Start price
06.06.21
/
50%
€0.017
Target price
06.06.22
€0.050
Performance (%)
-35.29%
End price
07.06.22
€0.011
Summary
This prediction ended on 07.06.22 with a price of €0.011. Massive losses of -35.29% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Hemogenyx Pharmaceuticals | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% |
According to melinda what are the pros and cons of Hemogenyx Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Hemogenyx Pharmaceuticals diskutieren
In the thread Trading Hemogenyx Pharmaceuticals
Die von melinda gewählte maximale Laufzeit wurde überschritten